William J. Venus, Managing Director
New Chronic Kidney Disease Outcomes Reporting Company Hires Director of Business Development
N. Amityville, N.Y.; December 1, 2005 – Clinical Outcomes Resource Application (CORA), a division of Bellco Health located in North Amityville, N.Y., announced the hiring of Sally Burrows-Hudson, MS, RN, CNN as the Director of Business Development. In her consulting role, Ms. Burrows-Hudson will be responsible for fostering key relationships with chronic kidney disease (CKD) stakeholders in growing and developing CORA in CKD stages 1-5.
“We are extremely pleased to have someone of Sally’s extensive background and expertise on board as we continue to build and launch our new company. Sally has over 25 years experience as a quality improvement, client services, and medical affairs professional. Her experience in holding key nephrology and senior level positions with the ESRD Network, Spectra Laboratories, Inc, Amgen, and Bone Care International since 1972 will be a tremendous asset to CORA’s mission of developing quality tools and additional resources for the independent renal provider market,” said Michael Lawlor, Executive Vice President.
Ms. Burrows-Hudson is an assistant clinical professor for the School of Nursing at the University of California at San Francisco, and is a former president of the American Nephrology Nurses’ Association and the National Federation of Specialty Nursing Organizations.
In August 2005, CORA was delighted to hire Jennifer Vavrinchik, MSN, RN, CNN as the Director of Clinical Services. Ms. Vavrinchik will be responsible for developing clinical resources and continuing education programs for the independent dialysis provider market.
Clinical Outcomes Resource Application (CORA) is a web-based clinical data collection & reporting company uniquely positioned to offer independent renal providers clinical performance assessments and benchmarking information to improve patient outcomes. CORA’s database contains de-identified clinical information in key areas specific to renal disease, including adequacy, anemia, bone disease, nutrition and vascular access information. CORA’s real time reporting capability enables providers to quickly drill down to patient level outliers with customized messages for medication changes; it benchmarks individual outcomes against regional and national statistics, provides clinical performance analysis via a “scorecard”; and it serves as a repository for customizing and monitoring clinical protocols.